Fluorodeoxyglucose positron emission tomography in primary thyroid lymphoma with coexisting lymphocytic thyroiditis

Thyroid

Volumn 21, Issue 10, 2011, Pages 1153-1156

  Arabi, Mohammad ^a,b   Dvorak, Ryan ^a,b   Smith, Lauren B ^a   Kujawski, Lisa ^c   Gross, Milton D ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; PREDNISONE; T LYMPHOCYTE RECEPTOR; THYROID PEROXIDASE ANTIBODY; THYROID TRANSCRIPTION FACTOR 1; VINCRISTINE SULFATE;

ADULT; ANTIBODY TITER; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONFERENCE PAPER; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG TUMOR LEVEL; DYSPHAGIA; FLOW CYTOMETRY; FOLLOW UP; GERMINAL CENTER; GOITER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LOBECTOMY; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; LYMPHOCYTIC THYROIDITIS; MALE; MEDIASTINUM LYMPH NODE; MULTIPLE CYCLE TREATMENT; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL T CELL LYMPHOMA; PRIMARY THYROID LYMPHOMA; PRIORITY JOURNAL; SEZARY SYNDROME; T CELL LEUKEMIA; T LYMPHOCYTE; THYROID CANCER; THYROID FOLLICLE; THYROTROPIN BLOOD LEVEL; TREATMENT RESPONSE; URTICARIA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMORBIDITY; CYCLOPHOSPHAMIDE; DIAGNOSIS, DIFFERENTIAL; DOXORUBICIN; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA; MALE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREDNISONE; THYROID NEOPLASMS; THYROIDITIS, AUTOIMMUNE; TREATMENT OUTCOME; VINCRISTINE;

EID: 80053200458     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0064     Document Type: Conference Paper

References (13)

1. Ansell SM, Grant CS, Habermann TM 1999 Primary thyroid lymphoma. Semin Oncol 26:316-323. (Pubitemid 29272899)
2. Sarinah B, Hisham AN 2010 Primary lymphoma of the thyroid: diagnostic and therapeutic considerations. Asian J Surg 33:20-24.
3. Anderson L, Middleton WD, Teefey SA, Reading CC, Langer JE, Desser T, Szabunio MM, Mandel SJ, Hildebolt CF, Cronan JJ 2010 Hashimoto thyroiditis: part 2, sonographic analysis of benign and malignant nodules in patients with diffuse Hashimoto thyroiditis. AJR Am J Roentgenol 195:216-222.
4. Ben-Ezra J, Wu A, Sheibani K 1988 Hashimoto's thyroiditis lacks detectable clonal immunoglobulin and T cell receptor gene rearrangements. Hum Pathol 19:1444-1448. (Pubitemid 19027549)
5. Holm LE, Blomgren H, Lowhagen T 1985 Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 312:601-604. (Pubitemid 15133674)
6. Widder S, Pasieka JL 2004 Primary thyroid lymphomas. Curr Treat Options Oncol 5:307-313. (Pubitemid 39139617)
7. Anderson L, Middleton WD, Teefey SA, Reading CC, Langer JE, Desser T, Szabunio MM, Hildebolt CF, Mandel SJ, Cronan JJ 2010 Hashimoto thyroiditis: part 1, sonographic analysis of the nodular form of Hashimoto thyroiditis. AJR Am J Roentgenol 195:208-215.
8. Casasnovas RO, Meignan M, Berriolo-Riedinger A, Bardet S, Julian A, Thieblemont C, Vera P, Bologna S, Brière J, Jais JP, Haioun C, Coiffier B, Morschhauser F 2011 SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma. Blood 118:37-43.
9. Basu S, Li G, Bural G, Alavi A 2009 Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility. Acta Radiol 50:201-204.
10. Lin EC 2007 FDG PET/CT for assessing therapy response in primary thyroid lymphoma. Clin Nucl Med 32:152-153. (Pubitemid 46148404)
11. Marchesi M, Biffoni M, Biancari F 2004 False-positive finding on 18F-FDG PET after chemotherapy for primary diffuse large B-cell lymphoma of the thyroid: a case report. Jpn J Clin Oncol 34:280-281. (Pubitemid 43102890)
12. Cohen MS, Arslan N, Dehdashti F, Doherty GM, Lairmore TC, Brunt LM, Moley JF 2001 Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 130:941-946. (Pubitemid 34014558)
13. Cohen T, Krausz Y, Nissan A, Ben-Yehuda D, Klein M, Freund HR 2006 18F-fluorodeoxyglucose-avid thyroid incidentalomas in patients with lymphoma. Isr Med Assoc J 8:720-721. (Pubitemid 44696917)